Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activation RA Meyer, JC Sunshine, K Perica, AK Kosmides, K Aje, JP Schneck, ... Small (Weinheim an der Bergstrasse, Germany) 11 (13), 1519, 2015 | 182 | 2015 |
Metabolomic fingerprinting: challenges and opportunities AK Kosmides, K Kamisoglu, SE Calvano, SA Corbett, I Androulakis Critical Reviews™ in Biomedical Engineering 41 (3), 2013 | 180 | 2013 |
Dual targeting nanoparticle stimulates the immune system to inhibit tumor growth AK Kosmides, JW Sidhom, A Fraser, CA Bessell, JP Schneck ACS nano 11 (6), 5417-5429, 2017 | 150 | 2017 |
Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanoma AK Kosmides, RA Meyer, JW Hickey, K Aje, KN Cheung, JJ Green, ... Biomaterials 118, 16-26, 2017 | 105 | 2017 |
Separating T cell targeting components onto magnetically clustered nanoparticles boosts activation AK Kosmides, K Necochea, JW Hickey, JP Schneck Nano letters 18 (3), 1916-1924, 2018 | 61 | 2018 |
Linking form to function: Biophysical aspects of artificial antigen presenting cell design K Perica, AK Kosmides, JP Schneck Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1853 (4), 781-790, 2015 | 52 | 2015 |
ImmunoMap: a bioinformatics tool for T-cell repertoire analysis JW Sidhom, CA Bessell, JJ Havel, A Kosmides, TA Chan, JP Schneck Cancer immunology research 6 (2), 151-162, 2018 | 41 | 2018 |
Engineering platforms for t cell modulation JW Hickey, AK Kosmides, JP Schneck International Review of Cell and Molecular Biology 341, 277-362, 2018 | 15 | 2018 |
Pulsatile glucocorticoid secretion: origins and downstream effects JD Scheff, AK Kosmides, SE Calvano, SF Lowry, IP Androulakis IEEE transactions on biomedical engineering 58 (12), 3504-3507, 2011 | 15 | 2011 |
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016 A Lundqvist, V van Hoef, X Zhang, E Wennerberg, J Lorent, K Witt, ... Journal for immunotherapy of cancer 4, 1-106, 2016 | 10 | 2016 |
ImmunoMap: a bioinformatics tool for T-cell repertoire analysis. Cancer Immunol. Res. 2018; 6: 151–162. doi: 10.1158/2326-6066 JW Sidhom, CA Bessell, JJ Havel, A Kosmides, TA Chan, JP Schneck CIR-17-0114.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 8 | |
Dual-targeting nanoparticles for reprogrammed T cell responses in the tumor microenvironment AK Kosmides, J Schneck Journal for ImmunoTherapy of Cancer 2 (Suppl 3), P108, 2014 | 2 | 2014 |
Immunoswitch nanoparticles for reprogrammed t cell responses AK Kosmides, JP Schenck US Patent App. 16/327,508, 2019 | 1 | 2019 |
Biomimicry of the Antigen Presenting Cell: The Importance of Size and Shape R Meyer, A Kosmides, JP Schneck, JJ Green TISSUE ENGINEERING PART A 22, S39-S39, 2016 | 1 | 2016 |
Production of antigen-specific t-cells M Oelke, JL Santos, S Kim, J Schneck, A Kosmides US Patent App. 18/111,975, 2023 | | 2023 |
Production of antigen-specific t-cells M Oelke, JL Santos, S Kim, J Schneck, A Kosmides US Patent App. 16/084,121, 2020 | | 2020 |
PRODUCTION OF T CELLS SPECIFIC TO ANTIGENS M Oelke, JL SANTOS, S Kim, J Schneck, A KOSMIDES | | 2019 |
Utilizing nanotechnology to improve the activation of CD8 T cells for cancer immunotherapy AK Kosmides Johns Hopkins University, 2018 | | 2018 |
Immunoswitch particles target activation of anti-tumor CD8+ T cells to inhibit tumor growth A Kosmides, JW Sidhom, A Fraser, C Bessell, J Schneck JOURNAL FOR IMMUNOTHERAPY OF CANCER 5, 2017 | | 2017 |
Production of antigen-specific t-cells M Oelke, JL Santos, S Kim, J Schneck, A KOSMIDES | | 2017 |